>
Functional Technologies logo

FEB.H - Functional Technologies Share Price

n/a 0.0  0.0%

Last Trade -

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £112k
Position in Universe th / 2700
Bullish
Bearish
Unlock FEB.H Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Aug 2007 2008 2009 2010 2011 2012 2013E 2014E CAGR / Avg
0.000 0.000 0.000 0.046 0.20 0.18
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 28 February 2013,Functional Technologies Corp revenues increased 83% toC$41K. Net loss decreased 75% to C$1.4M. Revenues reflectan increase in demand for the Company's products andservices due to favorable market conditions. Lower net lossreflects Salaries and wages decrease of 38% to C$540K(expense), Consulting decrease of 49% to C$178K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

FEB.H Revenue Unlock FEB.H Revenue

Net Income

FEB.H Net Income Unlock FEB.H Revenue

Normalised EPS

FEB.H Normalised EPS Unlock FEB.H Revenue

PE Ratio Range

FEB.H PE Ratio Range Unlock FEB.H Revenue

Dividend Yield Range

FEB.H Dividend Yield Range Unlock FEB.H Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
FEB.H EPS Forecasts Unlock FEB.H Revenue
Profile Summary

Functional Technologies Corp. is a Canada-based company which no longer has any operations. Previously, the Company was engaged in development and commercialization of yeast-based solutions for the food, beverage and healthcare industries.

Directors
Last Annual August 31st, 2012
Last Interim February 28th, 2013
Incorporated October 18, 1999
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange TSX Venture Exchange
Shares in Issue 61,370,444
Free Float (0.0%)
Eligible for
ISAs
SIPPs
FEB.H Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FEB.H
Upcoming Events for FEB.H
Frequently Asked Questions for Functional Technologies
What is the Functional Technologies share price?

As of , shares in Functional Technologies are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Functional Technologies share price performed this year?

Shares in Functional Technologies are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Functional Technologies price has moved by % over the past year.

What are the analyst and broker recommendations for Functional Technologies?

There are no analysts currently covering Functional Technologies.

When will Functional Technologies next release its financial results?

Functional Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2014-02-28
What is the Functional Technologies dividend yield?

Functional Technologies does not currently pay a dividend.

Does Functional Technologies pay a dividend?

Functional Technologies does not currently pay a dividend.

When does Functional Technologies next pay dividends?

Functional Technologies does not currently pay a dividend.

How do I buy Functional Technologies shares?

To buy shares in Functional Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Functional Technologies?

Shares in Functional Technologies are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are Functional Technologies shares listed? Where are Functional Technologies shares listed?

Here are the trading details for Functional Technologies:

Country of listing: Canada
Exchange: NEX
Ticker Symbol: FEB.H
What kind of share is Functional Technologies?

We were not able to load our ranking data for Functional Technologies

Is there a Functional Technologies share price forecast 2021?

We were not able to load any forecast data for Functional Technologies.

How can I tell whether the Functional Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Functional Technologies. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in Functional Technologies are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Functional Technologies PE Ratio?

We were not able to find PE ratio data for Functional Technologies.

Who are the key directors of Functional Technologies?

We were unable to find the directors for Functional Technologies.

Who are the major shareholders of Functional Technologies?

Here are the top five shareholders of Functional Technologies based on the size of their shareholding:

Similar to FEB.H
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.